Structure and function of the intercellular junctions: Barrier of paracellular drug delivery

被引:32
作者
Zheng, Kai [1 ]
Trivedi, Maulik [1 ]
Siahaan, Teruna J. [1 ]
机构
[1] Univ Kansas, Simons Res Labs, Dept Pharmaceut Chem, Lawrence, KS 66047 USA
关键词
blood-brain barrier; claudin; drug delivery; E-cadherin; intestinal mucosa; JAM; paracellular permeation; tight junctions;
D O I
10.2174/138161206777947722
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The delivery of large hydrophilic molecules (i.e., peptides and proteins) across biological barriers has been hampered by the presence of tight junctions. This delivery process can be improved by enhancing permeation through intercellular junctions of the intestinal mucosa and blood-brain barriers. This is achieved by modulating the intercellular junctions of these biological barriers. To modulate intercellular junctions, it is necessary to understand the structure and function of the proteins that are involved in these junctions. This review focuses on the structure of intercellular junctions and possible mechanisms of intercellular junction formation. Modulation of protein-protein interactions has been shown to increase the porosity of the paracellular pathway. For example, E-cadherin derived peptides have been shown to enhance the permeation of hydrophilic molecules (i.e., mannitol) in cell culture models of biological barriers.
引用
收藏
页码:2813 / 2824
页数:12
相关论文
共 108 条
[1]   QUANTITATIVE APPROACHES TO DELINEATE PARACELLULAR DIFFUSION IN CULTURED EPITHELIAL-CELL MONOLAYERS [J].
ADSON, A ;
RAUB, TJ ;
BURTON, PS ;
BARSUHN, CL ;
HILGERS, AR ;
AUDUS, KL ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (11) :1529-1536
[2]   Analysis of heterophilic and homophilic interactions of cadherins using the c-jun/c-fos dimerization domains [J].
Ahrens, T ;
Pertz, O ;
Häussinger, D ;
Fauser, C ;
Schulthess, T ;
Engel, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) :19455-19460
[3]   TIGHT JUNCTIONS AND THE MOLECULAR-BASIS FOR REGULATION OF PARACELLULAR PERMEABILITY [J].
ANDERSON, JM ;
VANITALLIE, CM .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (04) :G467-G475
[4]   Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor [J].
Arrate, MP ;
Rodriguez, JM ;
Tran, TM ;
Brock, TA ;
Cunningham, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) :45826-45832
[5]   Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond [J].
Artursson, P ;
Borchardt, RT .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1655-1658
[6]   JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells [J].
Aurrand-Lions, M ;
Duncan, L ;
Ballestrem, C ;
Imhof, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) :2733-2741
[7]   Are the extracelluar pathways a conduit for the delivery of therapeutics to the brain? [J].
Banks, WA .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (12) :1365-1370
[8]   Current biological therapies for inflammatory bowel disease [J].
Baumgart, DC ;
Dignass, AU .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (32) :4127-4147
[9]   Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin [J].
Bazzoni, G ;
Martínez-Estrada, OM ;
Orsenigo, F ;
Cordenonsi, M ;
Citi, S ;
Dejana, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20520-20526
[10]   The tight junction protein ZO-2 contains three PDZ ((P)under-barSD-95/(d)under-bariscs-large/(Z)under-barO-1) domains and an alternatively spliced region [J].
Beatch, M ;
Jesaitis, LA ;
Gallin, WJ ;
Goodenough, DA ;
Stevenson, BR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :25723-25726